ATE232867T1 - Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen - Google Patents
Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungenInfo
- Publication number
- ATE232867T1 ATE232867T1 AT96911227T AT96911227T ATE232867T1 AT E232867 T1 ATE232867 T1 AT E232867T1 AT 96911227 T AT96911227 T AT 96911227T AT 96911227 T AT96911227 T AT 96911227T AT E232867 T1 ATE232867 T1 AT E232867T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- tetronsic
- hiv
- pct
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40732295A | 1995-03-20 | 1995-03-20 | |
| PCT/US1996/002680 WO1996029333A1 (en) | 1995-03-20 | 1996-03-07 | Substituted tetronic acids useful for treating hiv and other retroviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232867T1 true ATE232867T1 (de) | 2003-03-15 |
Family
ID=23611540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96911227T ATE232867T1 (de) | 1995-03-20 | 1996-03-07 | Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6060600A (de) |
| EP (1) | EP0817786B1 (de) |
| JP (1) | JPH11503416A (de) |
| AT (1) | ATE232867T1 (de) |
| AU (1) | AU5417696A (de) |
| DE (1) | DE69626276T2 (de) |
| DK (1) | DK0817786T3 (de) |
| ES (1) | ES2191095T3 (de) |
| PT (1) | PT817786E (de) |
| SI (1) | SI0817786T1 (de) |
| WO (1) | WO1996029333A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| JP3726684B2 (ja) * | 2001-01-11 | 2005-12-14 | 株式会社Ｋｄｄｉ研究所 | 動画像データ転送における輻輳を回避する通信システム |
| DE102006039912A1 (de) * | 2006-08-25 | 2008-03-20 | Bayer Healthcare Ag | Substituierte Spirotetronsäuren und ihre Verwendung |
| DE102006059319A1 (de) * | 2006-12-15 | 2008-06-19 | Bayer Healthcare Ag | Substituierte Aminofuranone und ihre Verwendung |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA852614B (en) * | 1985-05-17 | 1986-10-09 | Takeda Chemical Industries, Ltd. | Ascorbic acid ethers and their production |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| ATE73789T1 (de) * | 1988-10-20 | 1992-04-15 | Shionogi & Co | Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren. |
| JP3156006B2 (ja) * | 1990-07-30 | 2001-04-16 | 武田薬品工業株式会社 | テトロン酸誘導体、その製造法及び用途 |
| EP0480624A1 (de) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | HIV Protease Hemmstoffe |
| AU2267992A (en) * | 1991-08-27 | 1993-03-16 | Upjohn Company, The | Compounds used for the inhibition of hiv-protease |
| EP0534907B1 (de) * | 1991-09-26 | 1998-08-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| IL108459A0 (en) * | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
| EP0720607A1 (de) * | 1993-09-17 | 1996-07-10 | PHARMACIA & UPJOHN COMPANY | Substituierte tetronsäuren zur behandlung von hiv und anderen retroviren |
-
1996
- 1996-03-07 JP JP8528429A patent/JPH11503416A/ja not_active Ceased
- 1996-03-07 EP EP96911227A patent/EP0817786B1/de not_active Expired - Lifetime
- 1996-03-07 PT PT96911227T patent/PT817786E/pt unknown
- 1996-03-07 DE DE69626276T patent/DE69626276T2/de not_active Expired - Fee Related
- 1996-03-07 AT AT96911227T patent/ATE232867T1/de not_active IP Right Cessation
- 1996-03-07 SI SI9630581T patent/SI0817786T1/xx unknown
- 1996-03-07 ES ES96911227T patent/ES2191095T3/es not_active Expired - Lifetime
- 1996-03-07 WO PCT/US1996/002680 patent/WO1996029333A1/en active IP Right Grant
- 1996-03-07 US US08/913,463 patent/US6060600A/en not_active Expired - Fee Related
- 1996-03-07 DK DK96911227T patent/DK0817786T3/da active
- 1996-03-07 AU AU54176/96A patent/AU5417696A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU5417696A (en) | 1996-10-08 |
| JPH11503416A (ja) | 1999-03-26 |
| DE69626276D1 (de) | 2003-03-27 |
| EP0817786A1 (de) | 1998-01-14 |
| US6060600A (en) | 2000-05-09 |
| SI0817786T1 (en) | 2003-08-31 |
| DK0817786T3 (da) | 2003-05-26 |
| ES2191095T3 (es) | 2003-09-01 |
| DE69626276T2 (de) | 2003-11-13 |
| EP0817786B1 (de) | 2003-02-19 |
| WO1996029333A1 (en) | 1996-09-26 |
| PT817786E (pt) | 2003-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9800080A (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
| DE69822665D1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| DE1300150T1 (de) | Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck | |
| ES2134764T3 (es) | Inhibidores de hiv proteasa. | |
| BR9812837A (pt) | Processo para fazer um composto, e, composto | |
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| DE69427344T2 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| BR9509975A (pt) | Formulação farmacêutica | |
| ES2132383T3 (es) | Inhibidores de proteasa hiv. | |
| DE69805305T2 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE232867T1 (de) | Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen | |
| DE69621786T2 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
| DE69838980D1 (de) | Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen | |
| DE69329687T2 (de) | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus | |
| BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
| DE3875016T2 (de) | Therapeutikum zur behandlung von aids. | |
| HUP0103712A2 (hu) | Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk | |
| DE69230790T2 (de) | Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen | |
| SE9402241L (sv) | Inhibitor | |
| ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
| DE68903930D1 (de) | Lipidemulsion zur behandlung von aids. | |
| FR2613621B1 (fr) | Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants | |
| SE9404438D0 (sv) | New process | |
| ATE121935T1 (de) | D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0817786 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |